Literature DB >> 25301113

The miRNA23b-regulated signaling network as a key to cancer development--implications for translational research and therapeutics.

Vignesh Viswanathan1,2, Jeremy Fields3, Bruce M Boman4,5.   

Abstract

A growing body of evidence indicates that microRNA23b (miR23b) is pleiotropic-it plays important roles in regulating physiological functions of cells, in regulating differentiation of cells and in regulating cellular immune responses. Our review of the literature showed that dysregulation of miR23b expression is implicated in the disruption of these cellular mechanisms and development of diseases such as cancer. MiR23b dysregulation appears to do this by modulating the expression level of candidate gene products involved in a network of signaling pathways including TGF-beta and Notch pathways that govern malignant properties of cancer cells such as motility and invasiveness. More recently, miR23b regulation of gene expression has also been associated with cancer stem cells and chemoresistance. Our review covers miR23b's role in immunity, endothelial function, differentiation, and cancer as well as its potential for translation into future cancer diagnostics and therapeutics.

Entities:  

Keywords:  Cancer stem cells; MiR23b; Signaling pathways

Mesh:

Substances:

Year:  2014        PMID: 25301113     DOI: 10.1007/s00109-014-1208-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  82 in total

1.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.

Authors:  Shu Zhu; Wen Pan; Xinyang Song; Yan Liu; Xinrui Shao; Yuanjia Tang; Dong Liang; Dongyi He; Honglin Wang; Wenjun Liu; Yufang Shi; John B Harley; Nan Shen; Youcun Qian
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

3.  Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB.

Authors:  Xian-Ming Chen; Steven P O'Hara; Jeremy B Nelson; Patrick L Splinter; Aaron J Small; Pamela S Tietz; Andrew H Limper; Nicholas F LaRusso
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

4.  Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles.

Authors:  Qin Liu; Ru-Tian Li; Han-Qing Qian; Jia Wei; Li Xie; Jie Shen; Mi Yang; Xiao-Ping Qian; Li-Xia Yu; Xi-Qun Jiang; Bao-Rui Liu
Journal:  Biomaterials       Date:  2013-06-24       Impact factor: 12.479

5.  Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth.

Authors:  Kuei-Chun Wang; Lana Xia Garmire; Angela Young; Phu Nguyen; Andrew Trinh; Shankar Subramaniam; Nanping Wang; John Y J Shyy; Yi-Shuan Li; Shu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-27       Impact factor: 11.205

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.

Authors:  Tong Sun; Qianben Wang; Steven Balk; Myles Brown; Gwo-Shu Mary Lee; Philip Kantoff
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

8.  Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

Authors:  Stephanie Ma; Kwok Wah Chan; Terence Kin-Wah Lee; Kwan Ho Tang; Jana Yim-Hung Wo; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

9.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

10.  Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.

Authors:  Mohd Saif Zaman; Sobha Thamminana; Varahram Shahryari; Takeshi Chiyomaru; Guoren Deng; Sharanjot Saini; Shahana Majid; Shinichiro Fukuhara; Inik Chang; Sumit Arora; Hiroshi Hirata; Koji Ueno; Kamaldeep Singh; Yuichiro Tanaka; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more
  6 in total

1.  Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.

Authors:  Javier Puente; Nuria Laínez; Marta Dueñas; María José Méndez-Vidal; Emilio Esteban; Daniel Castellano; Mónica Martinez-Fernández; Laura Basterretxea; María José Juan-Fita; Luis Antón; Luis León; Julio Lambea; Begoña Pérez-Valderrama; Sergio Vázquez; Cristina Suarez; Xavier Garcia Del Muro; Enrique Gallardo; José Pablo Maroto; M Luz Samaniego; Beatriz Suárez-Paniagua; Julián Sanz; Jesús M Paramio
Journal:  Oncotarget       Date:  2017-05-02

2.  MicroRNA Expression Profiling of Normal and Malignant Human Colonic Stem Cells Identifies miRNA92a as a Regulator of the LRIG1 Stem Cell Gene.

Authors:  Vignesh Viswanathan; Lynn Opdenaker; Shirin Modarai; Jeremy Z Fields; Gregory Gonye; Bruce M Boman
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

3.  Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.

Authors:  Dinglian Mei; Yalong Qi; Yuanyuan Xia; Jun Ma; Hao Hu; Jun Ai; Liqiang Chen; Ning Wu; Daixiang Liao
Journal:  World J Surg Oncol       Date:  2021-10-23       Impact factor: 2.754

4.  Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo.

Authors:  Hoda Y Abdallah; Noura R Abdelhamid; Eman A Mohammed; Nehal Y AbdElWahab; Noha Z Tawfik; Amal H A Gomaa; Eman A Toraih; Alia Ellawindy
Journal:  Sci Rep       Date:  2022-08-08       Impact factor: 4.996

5.  Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.

Authors:  Anna Palatnik; Shuyun Ye; Christina Kendziorski; Marissa Iden; Jessica S Zigman; Martin J Hessner; Janet S Rader
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

6.  miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.

Authors:  Quanbo Ji; Xiaojie Xu; Ling Li; Stuart B Goodman; Wenzhi Bi; Meng Xu; Yameng Xu; Zhongyi Fan; William J Maloney; Qinong Ye; Yan Wang
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.